Fetal Bovine Serum Market Size, Share, Growth, and Industry Analysis, By Source (North America-Sourced, South America-Sourced & Australia-Sourced), By Application (Scientific Research & Industrial Production), and Regional Forecast to 2033

FETAL BOVINE SERUM MARKET OVERVIEW

Fetal Bovine Serum Market Size was estimated at USD 945.41 million in 2024 and it is expected to grow from USD 976.61 million in 2025 to USD 1042.12 million by 2033. The Market CAGR (growth rate) is expected to be around 3.3% during the forecast period (2025 - 2033).

The fetal bovine serum (FBS) market forms a large part of the biopharmaceutical and biotechnology markets since FBS is used as an additive for most cell culture media owing to its nutritive value, promoting cell growth in tissue culture conditions. Obtained from the blood of bovine fetuses, FBS is consistently in demand for drug development, the production of vaccines, as well as in research-related activities, among others. Biomaterials are an essential component of FBS, and growth is further driven by progression in the biopharmaceutical industry, research activities, and shifting emphasis on regenerative treatments. Nevertheless, ethical issues and restrictions resulting from regulatory legislation of animal products bring problems in the process of market growth.

• • 

    Request a Free sample to learn more about this report.

GLOBAL CRISES IMPACTING FETAL BOVINE SERUM MARKET - COVID-19 IMPACT

"Fetal Bovine Serum Industry Had a Negative Effect Due to Supply shortages during COVID-19 Pandemic"

The Global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

The Ongoing COVID-19 pandemic had a strong effect on the fetal bovine serum (FBS) market that caused higher FBS consumption and production as research activities were growing during the development of vaccines and therapy. Due to the existing necessity for the vaccines as well as treatments against this virus, cell culture processes in the biopharmaceutical company increased, and as a result, FBS was consumed. This boosted the adoption of FBS, especially for usage in cell cultures, making the market for FBS grow during the period of the pandemic. Further, the advancement of the spending in biotechnology and vaccine development created the premises and the allure for the faster continuation and growth of the FBS market post-affected pandemic.

LATEST TREND

"Market growth focuses on sustainable, serum-free, and ethical alternatives"

New trends of the fetal bovine serum (FBS) industry are characterized by a gradual shift towards the development of innovative serum products and advancements in sustaining the supply chain. Some of these are the launching of serum-free and xeno-free media, which have gained much traction due to controversy surrounding the use of animal-derived components and to get consistent and reproducible data. This shift increases the need to find a substitute for FBS either by synthesizing it or using plant sources as a bid to cut on the use of animal products. As the strategies of researchers evolved towards an increase in reproducibility and sourcing supply chains became more focused on ethical sourcing, the market is to gradually undergo a positive change to provide more sustainable cell culture options.

FETAL BOVINE SERUM MARKET SEGMENTATION

By Source

Based on Source, the global market can be categorized into North America-Sourced, South America-Sourced & Australia-Sourced

• North America-Sourced: The North American-sourced Fetal Bovine Serum (FBS) market has shown increasing demand due to the presence of key biotechnology and pharmaceutical companies. This region is endowed with developed research facilities and has made tremendous investments in research, especially in stem cell and vaccine research. Furthermore, regulations on the qualities of products in North America remain high, which makes FBS products the best for different uses.

• South America-Sourced: The fetal bovine serum market sourced from South America has gained considerable growth due to the readily available livestock resource and relatively cheaper costs. Brazil and Argentina are major suppliers of competitively priced FBS with products that satisfy the quality standards of the world market. Also, the increased concern towards the production of biopharmaceuticals in South America has led to the need for FBS products from the same region.

• Australia-Sourced: The Australian-sourced fetal bovine serum market has a major emphasis on animal-derived reagents and highly acceptable processes, which are preferred by researchers who are sensitive to the welfare of animals. Australia has built strict regulation measures towards animal husbandry, and hence FBS enjoys the enhanced quality towards meeting the global market standards. In addition, an increasing trend in funding was observed for biotechnology research within Australia, where local-sourced FBS is used in some of the applications.

By Application

Based on Application, the global market can be categorized into Scientific Research & Industrial Production

• Scientific Research: Fetal Bovine Serum (FBS) has numerous applications in scientific research and is the most important supplement in cell culture media, sera, and reagents used for multiple purposes such as drug development, cancer, and stem cell research. Some authors use FBS for its high nutrient content that provides cell metabolism and proliferation, which results in higher reliability of experiments. A growing emphasis on experimental therapy and genomic medicine results in higher values of FBS demand in research centers and laboratories globally.

• Industrial Production: In industrial production, fetal bovine serum is mainly used in the production of vaccines and biopharmaceuticals as a source of nutrients for the cell lines used in the production process. This is transpiring in light of the emerging industry for biopharmaceuticals and the progression of personalized medicine that has increased the dependence of scientists on FBS to maximize cell culture outcomes. Since the rise of large-scale industrialization, there are ever-increasing needs for high-quality FBS to advance therapeutic development and improve the efficacy of vaccines.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities and challenges stating the market conditions.

Driving Factor

"Market growth driven by rising demand for biopharmaceuticals"

One of the biggest opportunities in the FBS market is the increased requirements for biopharmaceuticals, as such products need testing and development within the context of cell culture. FBS is vital in growing mammalianroblems concerning sourcing and their usage regulation, which is why researchers and companies look for alternatives. Although this shift towards ethical sourcing may reduce FBS and enhance the use of serum-free or xeno-free culture media.

Opportunity

"Market growth driven by emerging regions' biotechnology and pharmaceutical advancements"

The fetal bovine serum (FBS) market has enormous growth prospects in emerging regions as key end users like the biotechnology and pharmaceutical sectors of the industry continue to evolve in those regions. Asia-Pacific countries and Latin American countries are continuously increasing in their research and development expenditures, which in turn have increased the demand for FBS of high quality for a number of uses. These regions are predicted to emerge as an instrumental player in demanding the FBS market and expanding it elsewhere since local production capabilities continue to develop alongside supportive regulations. This trend poses a significant prospect for FBS suppliers to explore new markets and develop widely to penetrate larger customers.

Challenge

"Market growth impacted by FBS supply chain issues and fluctuations"

A major issue being experienced in the Fetal Bovine Serum (FBS) industry today is its supply chain factor, which relies heavily on livestock production and logistical channels. Fluctuations triggered by events like disease outbreaks that affect cattle, shifts in legislation, or usher in geopolitical tensions can cause shortages and a higher price of FBS. Furthermore, an increase in demand can result in a high fluctuation of the supply, hence leading to high costs of the FBS, thus affecting the user industries and research. This relationship makes use of a complicated supply chain, which must therefore ensure that there are plans to minimize risks and diversify to guarantee consistent supply.

• • 

    Request a Free sampleto learn more about this report.

FETAL BOVINE SERUM MARKET REGIONAL INSIGHTS

North America

"Market growth in North America driven by biotechnology and research investment"

Hence, North America remains the largest consuming region in the fetal bovine serum (FBS) market, mainly due to the established biotechnology industry, high research investment, and presence of key industry players. Among the main contributors of global United State fetal bovine serum market is the increased scientific research activities along with a growing demand for FBS in vaccines and therapeutics. Moreover, highly strict requirements for the quality and safety of FBS products consolidate the leading position of the region. Such factors make it easier for the market for FBS in North America to experience incremental improvements and changes in its products and services.

Europe

"Market growth in Europe driven by biotechnology, pharmaceuticals, and regulations"

Europe holds remarkable Fetal Bovine Serum (FBS) Market share, especially due to the strong biotechnology and pharmaceutical industries that are centralized in Europe. AT, RM, and PHC embedded in the region are contributing to the high demand for advanced-quality FBS across applications such as cell culture and vaccine production. Also, implementing regulatory measures to the FBS guarantees that the sourced product from Europe provides the appropriate ethical and MBA quality to researchers and manufacturers. In this context, it seems logical that the European market will experience further development and investment in applications connected to FBS in the future.

Asia

"Market growth in Asia driven by biotechnology and pharmaceutical advancements"

Asia is also expected to incline in the fetal bovine serum (FBS) market due to the progression of its biotechnology and pharmaceuticals pushing research and development. New actors such as China and India are emerging, with increasing needs for FBS in the production of vaccines and oncological studies as well as in cell cultures. Growth of the health care industry and emphasis on development of the biopharmaceutical industry in the region have also placed greater demand on FBS. Having identified that as the infrastructure and regulation develop, Asia is set to experience growth in demand for the FBS market that reaches out to global suppliers and researchers.

KEY INDUSTRY PLAYERS

"Market growth driven by partnerships, innovation, and sustainable sourcing practices"

It is found that industry participants are making substantial impacts on the fetal bovine serum (FBS) market through partnerships, product overtures, and geographic diversification. These flows are directed at research and development, improving FBS quality and its uses, and supporting the development of cell culture technologies through negotiation with research organizations. In the same manner, these firms are now paying more attention to ethical sourcing and sustainability to keep up with market trends.

List of Top Fetal Bovine Serum Companies

• Thermo Fisher (US)
• Cytiva ( US)
• Merck (US)
• MoregateBioTech (Australia)
• Gemini (US)

KEY INDUSTRY DEVELOPMENT

March 2024: Thermo Fisher Scientific launched a new GMP-grade fetal bovine serum (FBS) product designed to meet the increasing demand for clinical cell therapies and biopharmaceutical applications. The product, branded as Gibco Fetal Bovine Serum, Qualified, GMP, is produced under Good Manufacturing Practice (GMP) guidelines to ensure higher quality and consistency, crucial for regulatory compliance in the production of cell-based therapies. This development is part of Thermo Fisher’s strategy to support the growing biomanufacturing sector, particularly in regenerative medicine and advanced therapeutic areas, where high-quality serum is critical for cell culture and bioprocessing.

REPORT COVERAGE

The Study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential Applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

This Research report examines the segmentation of the market by using both quantitative and qualitative methods to provide a thorough analysis that also evaluates the influence of strategic and financial perspectives on the market. Additionally, the report's regional assessments consider the dominant supply and demand forces that impact market growth. The competitive landscape is detailed meticulously, including shares of significant market competitors. The report incorporates unconventional research techniques, methodologies and key strategies tailored for the anticipated frame of time. Overall, it offers valuable and comprehensive insights into the market dynamics professionally and understandably.